Glycopyrrolate(CAS: 596-51-0)

Glycopyrrolate (CAS: 596-51-0) must comply with the Globally Harmonized System of Classification and Labelling of Chemicals (GHS) for hazardous substances. In the European Union, it falls under REACH regulations and may require a Substance Information Exchange Forum (SIEF) for compliance. In the USA, FDA and EPA regulations apply, particularly for its use in pharmaceuticals and environmental releases.

There are several alternatives to Glycopyrrolate (CAS: 596-51-0) in synthesis, including other quaternary ammonium compounds and glycopyrrolate analogs. Common reagents include 1-alkyl-3-[(2-hydroxyethoxy)methyl]-1-propanaminium chloride, which can serve as a suitable alternative depending on the specific requirements of the reaction.

The market for Glycopyrrolate (CAS: 596-51-0) is steadily growing, driven by its use as an anticholinergic agent in various medical applications. Research trends focus on its potential in treating conditions such as chronic obstructive pulmonary disease (COPD) and myasthenia gravis. Price trends indicate stability, with increasing demand in pharmaceutical applications.

Waste containing Glycopyrrolate (CAS: 596-51-0) should be collected in appropriate containers labeled with the hazardous material symbol. It should be incinerated or disposed of professionally to avoid environmental contamination. Proper disposal requires adherence to local regulations and should be managed by trained personnel to ensure safety and compliance with environmental protection laws.